Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.90%12.57B | 10.60%46.36B | 13.62%10.94B | 25.31%41.91B | 18.56%11B | 22.04%10.87B | 29.25%10.42B | 33.62%9.63B | 64.87%33.45B | 32.03%9.28B |
| Cost of revenue | 20.06%3.96B | 13.68%14.58B | 12.82%3.3B | 28.20%12.83B | 17.69%3.31B | 23.31%3.34B | 36.04%3.25B | 39.71%2.92B | 67.32%10.01B | 42.08%2.81B |
| Gross profit | 12.67%8.61B | 9.24%31.77B | 13.96%7.64B | 24.07%29.09B | 18.93%7.69B | 21.49%7.52B | 26.39%7.17B | 31.13%6.7B | 63.84%23.44B | 28.09%6.47B |
| Operating expense | 11.70%7.72B | 10.90%28.65B | 16.09%6.91B | 17.31%25.84B | 21.03%7.14B | 13.70%6.48B | 16.44%6.26B | 17.94%5.95B | 31.56%22.03B | 20.43%5.9B |
| Operating profit | 21.95%888.65M | -3.92%3.12B | -2.88%728.72M | 129.20%3.25B | -2.88%550.24M | 112.36%1.04B | 205.93%910.77M | 1,061.03%750.36M | 158.25%1.42B | 279.21%566.58M |
| Net non-operating interest income (expenses) | 19.52%-4.02M | -74.70%-24.65M | -46.34%-5M | 12.23%-14.11M | -11.88%-4.24M | 18.62%-3.21M | 16.60%-3.25M | 23.25%-3.42M | 34.92%-16.08M | 25.07%-3.79M |
| Non-operating interest income | 734.62%4.97M | 847.87%3.78M | 1,819.35%595K | 638.89%399K | --339K | -3.33%29K | --0 | 29.17%31K | 80.00%54K | --0 |
| Non-operating interest expense | 60.69%8.99M | 95.96%28.44M | 62.29%5.59M | -10.05%14.51M | 20.83%4.58M | -18.50%3.24M | -16.60%3.25M | -22.97%3.45M | -34.78%16.13M | -25.07%3.79M |
| Net investment income | 4,484.35%17.28M | -60.79%1.34M | -85.20%377K | -58.14%3.42M | -164.85%-1.33M | 2.79M | -584K | 2.55M | 8.17M | 2.05M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -3.07M | -11.63M | 0 | |||||||
| Special income (charges) | 941.59%98.38M | 36.86%-47.44M | 379.69%9.45M | 79.04%-75.13M | 75.06%-63.95M | -2,648.19%-19.72M | 108.70%11.92M | -109.91%-3.38M | -202.41%-358.51M | -110.44%-256.39M |
| Less:Other special charges | -941.59%-98.38M | 94.58%-1.09M | -102.73%-9.45M | 67.35%-20.19M | 85.95%-1.72M | -144.83%-1.9M | 19.22%-11.92M | 86.33%-4.66M | -672.93%-61.83M | -159.12%-12.22M |
| Less:Write off | ---- | -49.08%48.53M | --0 | -77.32%95.32M | -75.55%65.66M | --21.62M | --0 | --8.04M | 232.16%420.34M | 112.26%268.61M |
| Other non-operating income (expenses) | -33.00%4.64M | -195.86%-10.08M | 1,569.16%6.93M | -5.81%-3.41M | -59.35%-5.68M | -10.12%533K | 174.53%1.32M | -72.68%415K | -100.07%-3.22M | -256.85%-3.56M |
| Income before tax | 35.30%1B | -4.13%3.03B | -0.81%740.47M | 201.54%3.16B | 55.81%475.05M | 106.85%1.02B | 493.42%920.18M | 679.35%746.53M | -43.10%1.05B | 1,129.74%304.89M |
| Income tax | -24.69%234.64M | 26.72%1.31B | 15.95%311.58M | 139.20%1.03B | -38.71%63.1M | 90.96%363.55M | 268.67%336.94M | 473.58%268.72M | -38.99%431.58M | 281.71%102.96M |
| Net income | 78.89%767.22M | -19.11%1.72B | -10.24%428.89M | 245.20%2.13B | 104.00%411.95M | 116.87%654.35M | 816.02%583.24M | 876.35%477.8M | -45.67%616.27M | 9,367.28%201.93M |
| Net income continuous operations | 78.89%767.22M | -19.11%1.72B | -10.24%428.89M | 245.20%2.13B | 104.00%411.95M | 116.87%654.35M | 816.02%583.24M | 876.33%477.8M | -45.67%616.27M | 9,367.28%201.93M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 78.89%767.22M | -19.11%1.72B | -10.24%428.89M | 245.20%2.13B | 104.00%411.95M | 116.87%654.35M | 816.02%583.24M | 876.35%477.8M | -45.67%616.27M | 9,367.28%201.93M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 78.89%767.22M | -19.11%1.72B | -10.24%428.89M | 245.20%2.13B | 104.00%411.95M | 116.87%654.35M | 816.02%583.24M | 876.35%477.8M | -45.67%616.27M | 9,367.28%201.93M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 78.77%66.52 | -18.75%149.23 | -9.75%37.21 | 245.37%183.67 | 104.53%35.65 | 116.90%56.46 | 815.09%50.33 | 877.01%41.23 | -45.67%53.18 | 9,273.68%17.43 |
| Diluted earnings per share | 78.77%66.52 | -18.75%149.23 | -9.75%37.21 | 245.37%183.67 | 104.59%35.65 | 116.90%56.46 | 816.02%50.3281 | 877.01%41.23 | -45.67%53.18 | 9,271.07%17.425 |
| Dividend per share | 0 | 58.62%46 | 0 | 190.00%29 | 283.33%23 | 0 | 50.00%6 | 0 | 150.00%10 | 50.00%6 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |